BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 18725309)

  • 1. Adenoviral-mediated interleukin-18 expression in mesenchymal stem cells effectively suppresses the growth of glioma in rats.
    Xu G; Jiang XD; Xu Y; Zhang J; Huang FH; Chen ZZ; Zhou DX; Shang JH; Zou YX; Cai YQ; Kou SB; Chen YZ; Xu RX; Zeng YJ
    Cell Biol Int; 2009 Apr; 33(4):466-74. PubMed ID: 18725309
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bone marrow-derived mesenchymal stem cells co-expressing interleukin-18 and interferon-β exhibit potent antitumor effect against intracranial glioma in rats.
    Xu G; Guo Y; Seng Z; Cui G; Qu J
    Oncol Rep; 2015 Oct; 34(4):1915-22. PubMed ID: 26252165
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The mixed human umbilical cord blood-derived mesenchymal stem cells show higher antitumor effect against C6 cells than the single in vitro.
    Jiao H; Yang B; Guan F; Li J; Shan H; Song L; Hu X; Liang S; Du Y; Jiang C
    Neurol Res; 2011 May; 33(4):405-14. PubMed ID: 21535940
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antitumor effect of genetically engineered mesenchymal stem cells in a rat glioma model.
    Nakamura K; Ito Y; Kawano Y; Kurozumi K; Kobune M; Tsuda H; Bizen A; Honmou O; Niitsu Y; Hamada H
    Gene Ther; 2004 Jul; 11(14):1155-64. PubMed ID: 15141157
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene therapy using TRAIL-secreting human umbilical cord blood-derived mesenchymal stem cells against intracranial glioma.
    Kim SM; Lim JY; Park SI; Jeong CH; Oh JH; Jeong M; Oh W; Park SH; Sung YC; Jeun SS
    Cancer Res; 2008 Dec; 68(23):9614-23. PubMed ID: 19047138
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The antitumor effect of mesenchymal stem cells transduced with a lentiviral vector expressing cytosine deaminase in a rat glioma model.
    Fei S; Qi X; Kedong S; Guangchun J; Jian L; Wei Q
    J Cancer Res Clin Oncol; 2012 Feb; 138(2):347-57. PubMed ID: 22139383
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intratumorally implanted mesenchymal stromal cells potentiate peripheral immunotherapy against malignant rat gliomas.
    Ströjby S; Eberstål S; Svensson A; Fritzell S; Bexell D; Siesjö P; Darabi A; Bengzon J
    J Neuroimmunol; 2014 Sep; 274(1-2):240-3. PubMed ID: 25086876
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo tracking of the tropism of mesenchymal stem cells to malignant gliomas using reporter gene-based MR imaging.
    Cao M; Mao J; Duan X; Lu L; Zhang F; Lin B; Chen M; Zheng C; Zhang X; Shen J
    Int J Cancer; 2018 Mar; 142(5):1033-1046. PubMed ID: 29047121
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gene therapy of intracranial glioma using interleukin 12-secreting human umbilical cord blood-derived mesenchymal stem cells.
    Ryu CH; Park SH; Park SA; Kim SM; Lim JY; Jeong CH; Yoon WS; Oh WI; Sung YC; Jeun SS
    Hum Gene Ther; 2011 Jun; 22(6):733-43. PubMed ID: 21261460
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Valproic acid enhances anti-tumor effect of mesenchymal stem cell mediated HSV-TK gene therapy in intracranial glioma.
    Ryu CH; Park KY; Kim SM; Jeong CH; Woo JS; Hou Y; Jeun SS
    Biochem Biophys Res Commun; 2012 May; 421(3):585-90. PubMed ID: 22525671
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rat multipotent mesenchymal stromal cells lack long-distance tropism to 3 different rat glioma models.
    Bexell D; Gunnarsson S; Svensson A; Tormin A; Henriques-Oliveira C; Siesjö P; Paul G; Salford LG; Scheding S; Bengzon J
    Neurosurgery; 2012 Mar; 70(3):731-9. PubMed ID: 21869725
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peritumoral administration of IFNβ upregulated mesenchymal stem cells inhibits tumor growth in an orthotopic, immunocompetent rat glioma model.
    Mao J; Cao M; Zhang F; Zhang J; Duan X; Lu L; Yang Z; Zhang X; Zhu W; Zhang Q; Wang Z; Shen J
    J Immunother Cancer; 2020 Mar; 8(1):. PubMed ID: 32169868
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic effect of suicide gene-transferred mesenchymal stem cells in a rat model of glioma.
    Kosaka H; Ichikawa T; Kurozumi K; Kambara H; Inoue S; Maruo T; Nakamura K; Hamada H; Date I
    Cancer Gene Ther; 2012 Aug; 19(8):572-8. PubMed ID: 22744211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of bone marrow stromal cells transfected with interleukin 18 on growth of intracranial glioma in rats].
    Li CH; Jiao BH
    Ai Zheng; 2007 Jan; 26(1):38-43. PubMed ID: 17222365
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recruited brain tumor-derived mesenchymal stem cells contribute to brain tumor progression.
    Behnan J; Isakson P; Joel M; Cilio C; Langmoen IA; Vik-Mo EO; Badn W
    Stem Cells; 2014 May; 32(5):1110-23. PubMed ID: 24302539
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The application of mRNA-based gene transfer in mesenchymal stem cell-mediated cytotoxicity of glioma cells.
    Guo XR; Yang ZS; Tang XJ; Zou DD; Gui H; Wang XL; Ma SN; Yuan YH; Fang J; Wang B; Zhang L; Sun XY; Warnock GL; Dai LJ; Tu HJ
    Oncotarget; 2016 Aug; 7(34):55529-55542. PubMed ID: 27487125
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of Two Types of Human Cells on Outgrowth of Human Glioma in Rats.
    Abdi Z; Eskandary H; Nematollahi-Mahani SN
    Turk Neurosurg; 2018; 28(1):19-28. PubMed ID: 27943226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo near-infrared imaging for the tracking of systemically delivered mesenchymal stem cells: tropism for brain tumors and biodistribution.
    Kim SM; Jeong CH; Woo JS; Ryu CH; Lee JH; Jeun SS
    Int J Nanomedicine; 2016; 11():13-23. PubMed ID: 26719691
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhancement of interleukin-4-mediated tumor regression in athymic mice by in situ retroviral gene transfer.
    Wei MX; Tamiya T; Hurford RK; Boviatsis EJ; Tepper RI; Chiocca EA
    Hum Gene Ther; 1995 Apr; 6(4):437-43. PubMed ID: 7612701
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Application of mesenchymal stem cells as a vehicle to deliver replication-competent adenovirus for treating malignant glioma.
    Hai C; Jin YM; Jin WB; Han ZZ; Cui MN; Piao XZ; Shen XH; Zhang SN; Sun HH
    Chin J Cancer; 2012 May; 31(5):233-40. PubMed ID: 22429494
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.